← back to search

Chang Xu

Institute of Hematology & Blood Diseases Hospital ·
Area of research
Molecular Biology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Effects of Radiation Exposure, DNA Repair Mechanisms, Carcinogens and Genotoxicity Assessment, and MicroRNA in disease regulation.
h-index
27
citations
3,348
works
117
NIH funding
primary concept
email

Recent publications

Integrated bulk and single-cell transcriptomic analysis unveiled a novel cuproptosis-related lipid metabolism gene molecular pattern and a risk index for predicting prognosis and antitumor drug sensitivity in breast cancer
Discover Oncology 2025cited by 10position: middledoi
Training and experimental validation a novel anoikis- and epithelial‒mesenchymal transition-related signature for evaluating prognosis and predicting immunotherapy efficacy in gastric cancer
Journal of Cancer 2025cited by 6position: middledoi
Avellanin A Has an Antiproliferative Effect on TP-Induced RWPE-1 Cells via the PI3K-Akt Signalling Pathway
Marine Drugs 2024cited by 5position: firstdoi
AGuIX nanoparticles enhance ionizing radiation-induced ferroptosis on tumor cells by targeting the NRF2-GPX4 signaling pathway
Journal of Nanobiotechnology 2022cited by 98position: middledoi
Radiosensitization Effect of AGuIX, a Gadolinium-Based Nanoparticle, in Nonsmall Cell Lung Cancer
ACS Applied Materials & Interfaces 2020cited by 57position: middledoi
PAICS contributes to gastric carcinogenesis and participates in DNA damage response by interacting with histone deacetylase 1/2
Cell Death and Disease 2020cited by 26position: middledoi
DNA double-strand breaks promote methylation of histone H3 on lysine 9 and transient formation of repressive chromatin
Proceedings of the National Academy of Sciences 2014cited by 391position: middledoi
Histone H2A.Z Controls a Critical Chromatin Remodeling Step Required for DNA Double-Strand Break Repair
Molecular Cell 2012cited by 332position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 2 papers (2020–2022)Ningning He · Sun Yat-sen University Cancer Center2 papers (2020–2022)Olivier Tillement · Université Claude Bernard Lyon 12 papers (2020–2022)Kaihua Ji · Nankai University2 papers (2020–2022) · 2 papers (2012–2014)Tristan Doussineau · Université Claude Bernard Lyon 12 papers (2020–2022)François Lux · Université Claude Bernard Lyon 12 papers (2020–2022)Yuhan Wei · Shandong University of Traditional Chinese Medicine2 papers (2025–2025)Brendan D. Price · Northeastern University2 papers (2012–2014) · 2 papers (2012–2014) · 2 papers (2020–2022)Hao Sun · Hebei Medical University2 papers (2020–2022)Jinhan Wang · Zhengzhou University2 papers (2020–2022)Yan Wang · Nanchang University2 papers (2020–2022)Yang Liu · Nanchang University2 papers (2020–2022)Yue Wang · Jiangsu University2 papers (2025–2025)Qiang Liu · Shandong Xiehe University2 papers (2020–2022)Qin Wang · Nanjing University of Chinese Medicine2 papers (2020–2022)Ye Xu · Guangzhou Medical University2 papers (2012–2014)Yi Xie · Chinese Academy of Sciences2 papers (2020–2022)